ESC 365 - HUYGENS: Evolocumab and changes in plaque composition on OCT

Open Access

HUYGENS: Evolocumab and changes in plaque composition on OCT

Session: Late Breaking Trials in ACS

Topic: Pharmacotherapy

Speaker: Professor S. Nicholls (Melbourne, AU)

Event: ESC Congress 2021 - The Digital Experience

Congress Session

About the speaker

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)

36 presentations

1 follower

3 more presentations in this session

QUORUM : Quantum Genomics Firibastat (QGC001) or Ramipril after Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction

Speaker: Professor G. Montalescot (Paris, FR)

ACCOST-HH: Adrecizumab in cardiogenic shock

Speaker: Doctor M. Karakas (Hamburg, DE)

Low-dose rivaroxaban during the acute phase of ACS - H-REPLACE Trial)

Speaker: Professor S. Zhou (Changsha, CN)

Access the full session

Late Breaking Trials in ACS

Speakers: Professor S. Nicholls, Professor G. Montalescot, Doctor M. Karakas, Professor S. Zhou

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

Open Access

What should we do when we are presented with an individual who has CVD and comorbid obesity?

27 August 2021

Open Access

What treatment options can cardiologists offer people with CVD and obesity?

27 August 2021

Open Access

Why do cardiologists need to care about treating obesity?

27 August 2021

This platform is supported by